FundedIQ

Recently Funded Convertible Note Biotechnology Startups

Updated Sep 2026

Funded Convertible Note Biotechnology startups number 23 in FundedIQ, tracked with their funding rounds, amounts, investors, industries, locations and company details. This page provides an overview of the Convertible Note Biotechnology startup funding landscape, along with the 23 most recently funded Convertible Note Biotechnology startups.

San Francisco and Alpharetta hold the deepest concentrations of these companies. Convertible Note Biotechnology startups closed 6 funding rounds over the last 24 months, 6 of them in the last 12 months, and raised $23M in disclosed capital. The median disclosed round is $5.5M, with the middle half of rounds falling between $3.5M and $5.8M.

Biotechnology ventures using convertible notes concentrate heavily within the United States. European activity remains significant across Germany, Switzerland, and France. This geographic spread means outreach covers several distinct international regions rather than a single city. Engagement involves navigating different regulatory zones and time zones to reach these mid sized teams.

Convertible Note Biotechnology funded startup statistics

Funded Convertible Note Biotechnology startups
23
tracked in the database
Funding rounds, last 12 months
6
6 over 24 months
Disclosed capital raised, 24 months
$23M
5 of 6 rounds disclosed an amount
Median round size
$5.5M
middle half $3.5M to $5.8M

Most recent funding round on record: Aug 2026.

23 most recently funded Convertible Note Biotechnology startups

23 shown

Ordered by the date of the latest funding round. Each row gives the company, its location and industry, what it does, the stage and date of that round, and the disclosed amount.

H
Lehi, United States · Biotechnology
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Convertible Note ·
$3.5M
N
Pittsburgh, United States · Biotechnology
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
Convertible Note ·
$6.8M
I
Minnesota City, United States · Biotechnology
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Convertible Note ·
$1.3M
P
Parnell, New Zealand · Biotechnology
Pictor is an in-vitro diagnostics company that offers a patented multiplexed platform for highly accurate and…
Convertible Note ·
Undisclosed
S
Grosse Pointe Farms, United States · Biotechnology
SciTech Development is a pharmaceutical company that specializes in cancer treatments. The company has…
Convertible Note ·
$5.5M
A
Rostock, Germany · Biotechnology
Artcline is a biotech company that creates diagnostic and therapeutic techniques for critical care medicine.
Convertible Note ·
$5.8M
E
Philadelphia, United States · Biotechnology
We are a clinical stage biopharmaceutical company engaged in the discovery and development of synthetic…
Convertible Note ·
$6.0M
G
Durham, United States · Biotechnology
GeneCentric Therapeutics engages in developing and commercializing molecular diagnostic tests for oncologists…
Convertible Note ·
$2.5M
A
Lake Forest, United States · Biotechnology
Assertio is a specialty pharmaceutical company focused on developing and commercializing products to treat…
Convertible Note ·
$60M
A
Newport Beach, United States · Biotechnology
AEON Biopharma is a biopharmaceutical company focused on the development of ABP-450, a proprietary 900…
Convertible Note ·
$30M
O
Barcelona, Spain · Biotechnology
Oryzon Genomics is a biopharmaceutical organization creating epigenetics-based therapeutics for patients with…
Convertible Note ·
$21M
S
South San Francisco, United States · Biotechnology
Our mission is to create a new generation of smarter medicines that outmaneuver complex diseases in ways…
Convertible Note ·
$5.2M
S
Raleigh, United States · Biotechnology
Sprout Pharmaceuticals develops products for the treatment of female sexual dysfunction. They're committed to…
Convertible Note ·
$25M
L
Alpharetta, United States · Biotechnology
LivFul is a biotechnology company that develops consumer products also offers healthcare solutions. It was…
Convertible Note ·
$750k
A
Lausanne, Switzerland · Biotechnology
ARTIRIA Medical provides micro-actuated device allowing to treat vascular diseases.
Convertible Note ·
$1.2M
C
Lancaster, United States · Biotechnology
CarthroniX is a pharmaceutical company that offers small molecule based therapy, wound healing, skin…
Convertible Note ·
$2.3M
F
San Francisco, United States · Biotechnology
Feel Therapeutics (FKA Sentio Solutions) is a San Francisco based company, which develops biomarkers and…
Convertible Note ·
$4.0M
C
San Francisco, United States · Biotechnology
Concentric Analgesics is a biotechnology company focused on developing non-opioid therapeutics for the…
Convertible Note ·
$20M
D
Boston, United States · Biotechnology
Delix Therapeutics is a neuroscience company focused on harnessing the power of psychoplastogens—novel…
Convertible Note ·
$30M
E
Cambridge, United States · Biotechnology
EnBiotix is a product-focused bioengineering company that advances front-line labeled products for chronic,…
Convertible Note ·
$11M
N
Geneva, Switzerland · Biotechnology
Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the…
Convertible Note ·
$100k
A
Lyon, France · Biotechnology
Adocia operates as a biotechnology company specializing in tissue regeneration. Adocia was founded in 2005 as…
Convertible Note ·
$7.0M
H
München, Germany · Biotechnology
HMNC Brain Health develops patented genetic tests and combines those with innovative exclusively in-licensed…
Convertible Note ·
$11M

Countries with the most funded Convertible Note Biotechnology startups

Where funded Convertible Note Biotechnology startups are headquartered, by the country on the company record.

Where are funded Convertible Note Biotechnology startups located?

Where funded Convertible Note Biotechnology startups are based, by the city on the company record.

About the FundedIQ Convertible Note Biotechnology startup funding data

FundedIQ tracks announced startup funding rounds and organises them by company, funding date, stage, amount, industry, location and investor. The dataset is refreshed weekly, and new rounds are normalised and de-duplicated before they are published, so the same round reported twice on different dates is recorded once.

Figures on this page cover the 23 funded Convertible Note Biotechnology startups currently tracked. Round counts, capital totals and the median round are computed over a trailing 24 months. Rounds whose amount was not disclosed (1 of 6 in that period) are counted as rounds but excluded from capital totals and from the median. The most recent round on record for funded Convertible Note Biotechnology startups is dated Aug 2026.

The table above shows the 23 most recently funded companies. Full funding histories, investor lists and founder contacts across the whole dataset open on a FundedIQ plan.

Frequently asked questions

How many funded Convertible Note Biotechnology startups are there?

FundedIQ tracks 23 funded Convertible Note Biotechnology startups. This page lists the 23 most recently funded of them, ordered by the date of their latest round, and the full set is available on a FundedIQ plan.

How much funding have Convertible Note Biotechnology startups raised?

Convertible Note Biotechnology startups tracked by FundedIQ have raised $23M in disclosed capital across 6 funding rounds over the last 24 months, including 6 rounds in the last 12 months. 5 of those 6 rounds disclosed an amount; undisclosed rounds are excluded from the capital total.

Which countries have the most funded Convertible Note Biotechnology startups?

United States leads with 16 companies, ahead of Germany (2), Switzerland (2) and France (1).

Which cities have the most funded Convertible Note Biotechnology startups?

San Francisco leads with 2 companies, then Alpharetta (1), Barcelona (1) and Boston (1).

What is a typical funding round size for Convertible Note Biotechnology startups?

The median disclosed round over the last 24 months is $5.5M, and the middle half of rounds fall between $3.5M and $5.8M. Round sizes vary widely by stage, so the seed and later-stage bands sit well either side of that figure.

How often is the Convertible Note Biotechnology startup funding data updated?

The dataset is refreshed weekly. New rounds are normalised and de-duplicated before they are published, and the most recent round currently on record for funded Convertible Note Biotechnology startups is dated Aug 2026. Counts and totals on this page are recomputed on every refresh.

Related listings

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.